Gsk GSK
NYSE GSK
$50.14 +2.01 (+4.18%)
As of: Sep 14, 2026 · 1:26 PM EDT

Gsk (GSK) Restructuring Costs (2009 - 2018)

Gsk (GSK) posted Restructuring Costs of $66.9 million for Q4 2018, down 67.49% quarter-over-quarter from $205.8 million in Q4 2017, and down 67.49% YoY from $205.8 million in Q4 2017.

Analysis

Gsk (GSK) Restructuring Costs (2009 - 2018) Analysis & Trends

Gsk (GSK) has 6 years of Restructuring Costs data on file, last reported at $66.9 million in Q4 2018.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 619.91 Bn 603.93 Bn 5.90 Bn
2 Hsbc Holdings 362.69 Bn 362.69 Bn -
3 General Electric 329.36 Bn 320.01 Bn 6.95 Bn
4 Astrazeneca 254.01 Bn 248.73 Bn 12.86 Bn
5 Citigroup 228.33 Bn -2,073.98 Bn 24.75 Bn
6 Bhp 215.97 Bn 197.42 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.54 Bn 195.50 Bn -
9 Unilever 139.09 Bn 132.06 Bn -
10 Gsk 101.58 Bn 101.58 Bn 15.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 66.91 Mn
Dec 31, 2017 205.79 Mn
Dec 31, 2016 -295.89 Mn
Mar 31, 2011 -216.19 Mn
Mar 31, 2010 -469.79 Mn
Mar 31, 2009 -379.36 Mn